Article
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
18 Nov 2019
Abstract excerpt
Bladder cancer (BC) is the most common neoplasia of the urothelial tract. Due to its high incidence, prevalence, recurrence and mortality, it remains an unsolved clinical and social problem. The treatment of BC is challenging and, although immunotherapies have revealed potential benefit in a percentage of patients, it remains mostly an incurable disease at its advanced state. Epigenetic alterations, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
